Coherus Oncology, Inc.
US ˙ NasdaqGM ˙ US19249H1032

SecurityCHRS / Coherus Oncology, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership547,209 shares
Latest Disclosed Value $ 924,783
UBS Group AG ownership in CHRS / Coherus Oncology, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 547,209 shares of Coherus Oncology, Inc. (US:CHRS) valued at $924,783 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 610,803 shares of Coherus Oncology, Inc.. This represents a change in shares of -10.41% during the quarter. The current value of the position is $804,397 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (CHRS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CHRS / Coherus Oncology, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F COHERUS ONCOLOGY COM 19249H103 547,209 -63,594 -10.41 925 6.57 0.0000
2026-01-29 2025-12-31 13F COHERUS ONCOLOGY COM 19249H103 610,803 -185,138 -23.26 867 -33.56 0.0000
2025-11-13 2025-09-30 13F COHERUS ONCOLOGY COM 19249H103 795,941 221,410 38.54 1,305 211.46 0.0002
2025-08-14 2025-06-30 13F COHERUS ONCOLOGY COM 19249H103 574,531 205,580 55.72 420 41.08 0.0001
2025-05-13 2025-03-31 13F COHERUS BIOSCIENCES COM 19249H103 368,951 -340,048 -47.96 298 -69.63 0.0001
2025-02-14 2024-12-31 13F COHERUS BIOSCIENCES COM 19249H103 708,999 535,830 309.43 978 443.33 0.0002
2024-11-14 2024-09-30 13F COHERUS BIOSCIENCES COM 19249H103 173,169 -12,371 -6.67 180 -43.75 0.0000
2024-08-14 2024-06-30 13F COHERUS BIOSCIENCES COM 19249H103 185,540 63,670 52.24 321 9.97 0.0001
2024-05-13 2024-03-31 13F COHERUS BIOSCIENCES COM 19249H103 121,870 -22,456 -15.56 291 -39.37 0.0001
2024-02-09 2023-12-31 13F COHERUS BIOSCIENCES COM 19249H103 144,326 -164,785 -53.31 481 -58.48 0.0001
2023-11-09 2023-09-30 13F COHERUS BIOSCIENCES COM 19249H103 309,111 306,958 14,257.22 1,156 12,744.44 0.0004
2023-08-11 2023-06-30 13F COHERUS BIOSCIENCES COM 19249H103 2,153 -203,259 -98.95 9 -99.36 0.0000
2023-05-12 2023-03-31 13F COHERUS BIOSCIENCES COM 19249H103 205,412 -100,237 -32.79 1,405 -41.94 0.0005
2023-02-08 2022-12-31 13F COHERUS BIOSCIENCES COM 19249H103 305,649 260,697 579.95 2,421 460.19 0.0009
2022-11-10 2022-09-30 13F COHERUS BIOSCIENCES COM 19249H103 44,952 -71,146 -61.28 432 -48.63 0.0002
2022-08-10 2022-06-30 13F COHERUS BIOSCIENCES COM 19249H103 116,098 12,237 11.78 841 -37.24 0.0003
2022-05-16 2022-03-31 13F COHERUS BIOSCIENCES COM 19249H103 103,861 -59,831 -36.55 1,340 -48.72 0.0004
2022-02-14 2021-12-31 13F COHERUS BIOSCIENCES COM 19249H103 163,692 40,930 33.34 2,613 32.44 0.0007
2021-11-15 2021-09-30 13F COHERUS BIOSCIENCES COM 19249H103 122,762 70,178 133.46 1,973 171.39 0.0006
2021-08-13 2021-06-30 13F COHERUS BIOSCIENCES COM 19249H103 52,584 -68,638 -56.62 727 -58.95 0.0002
2021-05-12 2021-03-31 13F COHERUS BIOSCIENCES COM 19249H103 121,222 108,462 850.02 1,771 701.36 0.0006
2021-02-11 2020-12-31 13F COHERUS BIOSCIENCES COM 19249H103 12,760 -3,475 -21.40 221 -25.84 0.0001
2020-11-12 2020-09-30 13F COHERUS BIOSCIENCES COM 19249H103 16,235 -7,919 -32.79 298 -30.86 0.0001
2020-07-31 2020-06-30 13F COHERUS BIOSCIENCES COM 19249H103 24,154 3,352 16.11 431 27.51 0.0002
2020-05-01 2020-03-31 13F COHERUS BIOSCIENCES COM 19249H103 20,802 -9,759 -31.93 338 -38.55 0.0002
2020-02-14 2019-12-31 13F COHERUS BIOSCIENCES COM 19249H103 30,561 -2,722 -8.18 550 -18.40 0.0002
2019-11-14 2019-09-30 13F COHERUS BIOSCIENCES COM 19249H103 33,283 -33,141 -49.89 674 -54.09 0.0003
2019-08-14 2019-06-30 13F COHERUS BIOSCIENCES COM 19249H103 66,424 39,794 149.43 1,468 304.41 0.0006
2019-05-14 2019-03-31 13F COHERUS BIOSCIENCES COM 19249H103 26,630 -181,404 -87.20 363 -80.72 0.0001
2019-02-14 2018-12-31 13F COHERUS BIOSCIENCES COM 19249H103 208,034 179,492 628.87 1,883 299.79 0.0009
2018-11-14 2018-09-30 13F COHERUS BIOSCIENCES COM 19249H103 28,542 11,679 69.26 471 99.58 0.0002
2018-08-14 2018-06-30 13F COHERUS BIOSCIENCES COM 19249H103 16,863 -64,039 -79.16 236 -73.60 0.0001
2018-05-15 2018-03-31 13F COHERUS BIOSCIENCES COM 19249H103 80,902 70,000 642.08 894 831.25 0.0004
2018-02-14 2017-12-31 13F COHERUS BIOSCIENCES COM 19249H103 10,902 -7,083 -39.38 96 -59.83 0.0000
2017-11-14 2017-09-30 13F COHERUS BIOSCIENCES COM 19249H103 17,985 6,148 51.94 239 39.77 0.0001
2017-11-14 2017-06-30 13F/A-1 COHERUS BIOSCIENCES COM 19249H103 11,837 9,107 333.59 171 194.83 0.0001
2017-08-14 2017-06-30 13F COHERUS BIOSCIENCES COM 19249H103 11,837 9,107 171
2017-11-14 2017-03-31 13F/A-1 COHERUS BIOSCIENCES COM 19249H103 2,730 -16,251 -85.62 58 -89.14 0.0000
2017-05-12 2017-03-31 13F COHERUS BIOSCIENCES COM 19249H103 2,730 -16,251 58
2017-02-14 2016-12-31 13F COHERUS BIOSCIENCES COM 19249H103 18,981 14,150 292.90 534 313.95 0.0003
2016-11-14 2016-09-30 13F COHERUS BIOSCIENCES COM 19249H103 4,831 871 21.99 129 92.54 0.0001
2016-08-12 2016-06-30 13F COHERUS BIOSCIENCES COM 19249H103 3,960 3,960 0.00 67 0.0000
2016-05-12 2016-03-31 13F COHERUS BIOSCIENCES COM 19249H103 0 -605 -100.00 0 -100.00
2016-02-16 2015-12-31 13F COHERUS BIOSCIENCES COM 19249H103 605 605 0.00 14 0.0000
2015-11-13 2015-09-30 13F COHERUS BIOSCIENCES COM 19249H103 0 -2,777 -100.00 0 -100.00
2015-08-14 2015-06-30 13F COHERUS BIOSCIENCES COM 19249H103 2,777 226 8.86 80 2.56 0.0001
2015-05-14 2015-03-31 13F COHERUS BIOSCIENCES COM 19249H103 2,551 1,866 272.41 78 609.09 0.0001
2015-02-17 2014-12-31 13F COHERUS BIOSCIENCES COM 19249H103 685 685 11 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-11-14 2018-09-30 13F COHERUS BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F COHERUS BIOSCIENCES COM Call 29,900 419 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-07-31 2020-06-30 13F COHERUS BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-01 2020-03-31 13F COHERUS BIOSCIENCES COM Put 20,000 0.00 324 -10.00 n/a n/a n/a
2020-02-14 2019-12-31 13F COHERUS BIOSCIENCES COM Put 20,000 122.22 360 97.80 n/a n/a n/a
2019-11-14 2019-09-30 13F COHERUS BIOSCIENCES COM Put 9,000 182 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.